ARCHIVES

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

This article is from The Cancer Letter archive.

Vol. 18 No. 24 | June 12, 1992

Download PDF Visit The Full Archive

Related Articles

MM-121 Study Fails PFS Endpoint, Biomarker Analysis Continues

November 29, 2013

FDA Tightens Conflict of Interest Rules For Advisors.

March 23, 2007

Stop Cancer Foundation’s Future In Question, May Not Deliver All Of Funds Promised to NCI

January 18, 1991

New Control Grant Guidelines Include Community Resources Development

August 22, 1975

Leukemia Biology Study Needed To Improve Results, Pinkel Says In Karnfsky Lecture

April 7, 1978

Carmona’s Term as Surgeon General Expires.

August 4, 2006